5 Key Takeaways

• 1

  Retina practices face challenges with rising drug costs, operational complexity, and the need for better support from GPOs and specialty distributors.

• 2

  Practices express frustration over opaque pricing, slow rebate payments, and the inefficiency of manual inventory reconciliation.

• 3

  There is a demand for strategic guidance and education on drug purchasing as biosimilars and payer dynamics evolve.

• 4

  Trust and transparency in partnerships with GPOs and specialty distributors are essential for long-term value and loyalty.

• 5

  AllyGPO and BioCareSD aim to provide flexible, transparent, and innovative solutions to enhance practice productivity and financial health.